G&E Herbal Biotechnology Co., Ltd. (4911.TWO) stock: key figures, P/E, revenue and dividend
Health Care · Taiwan
G&E Herbal Biotechnology Co., Ltd. financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 249.03 m TWD | 309.13 m TWD |
| Gross profit | 205.34 m TWD | 263.22 m TWD |
| Operating income | 119.65 m TWD | 152.30 m TWD |
| EBIT | 124.77 m TWD | 158.42 m TWD |
| Net income | 102.06 m TWD | 139.20 m TWD |
| Diluted EPS – continuing operations | 1.48 TWD | 2.02 TWD |
Full history since 2021, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About G&E Herbal Biotechnology Co., Ltd.
G&E Herbal Biotechnology Co., Ltd. engages in manufacturing and wholesale of western and chinese medicine, cosmetics, intellectual property rights, biotechnology services, medical device, and other unclassified food products in Taiwan. It offers HepaGent capsules, a liver protective agent; botanical food supplements; botanical anti-aging cosmetics, such as facial cleansing essence, botanic extract toner, moisturizing cream and serum, and essential oil; smile cream and topical gel; as well as lubricants. G&E Herbal Biotechnology Co., Ltd. was founded in 2002 and is based in Tainan City, Taiwan.
More stocks
- Fy Grp Ltd (6807.TW)
- WooriNet Inc (115440.KQ)
- PT Pancaran Samudera Transport Tbk (PSAT.JK)
- Intrepid Metals Corp (INTR.V)
- Airship AI Holdings, Inc. (AISP)
- Shinih Enterprise Co Ltd (9944.TW)
- Everspring Industry Co Ltd (2390.TW)
- Tailim Packaging Co Ltd (011280.KS)
- Stablecoin Development Corp (SDEV)
- Hansol Csn (009180.KS)
- Crystalvue Medical Corporation (6527.TWO)
- NS Co. Ltd (217820.KQ)
Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.